Cumberland Pharmaceuticals (CPIX) Capital Expenditures Growth (5y) (2015 - 2026)
Cumberland Pharmaceuticals (CPIX) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.49% |
| Dec 31, 2025 | -14.87% |
| Sep 30, 2025 | -11.70% |
| Jun 30, 2025 | -1.22% |
| Mar 31, 2025 | 15.95% |
| Dec 31, 2024 | -50.87% |
| Sep 30, 2024 | -27.61% |
| Jun 30, 2024 | -34.94% |
| Mar 31, 2024 | 8.66% |
| Dec 31, 2023 | -29.72% |
| Sep 30, 2023 | 5.82% |
| Jun 30, 2023 | 14.43% |
| Mar 31, 2023 | 2.48% |
| Dec 31, 2022 | -28.40% |
| Sep 30, 2022 | 25.18% |
| Jun 30, 2022 | 48.19% |
| Mar 31, 2022 | -26.28% |
| Dec 31, 2021 | -22.61% |
| Sep 30, 2021 | 16.60% |
| Jun 30, 2021 | 50.77% |